Financial Ratios

BRAWN BIOTECH LTD.

NSE : NABSE : 530207ISIN CODE : INE899B01015Industry : TradingHouse : Private
BSE26.500 (0 %)
PREV CLOSE ( ) 26.50
OPEN PRICE ( ) 26.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3
TODAY'S LOW / HIGH ( )26.50 26.50
52 WK LOW / HIGH ( ) 14.427.47
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.89-5.48-1.841.974.44
   CEPS(Rs)-2.53-5.30-1.722.094.55
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)21.0324.0729.3130.8728.85
   Tax Rate(%)-110.9622.35-52.9927.8726.17
Margin Ratios
   Core EBITDA Margin(%)-1.36-23.26-1.711.481.79
   EBIT Margin(%)-1.81-23.84-0.921.762.88
   Pre Tax Margin(%)-1.85-24.57-1.031.652.77
   PAT Margin (%)-3.91-19.08-1.571.192.04
   Cash Profit Margin (%)-3.41-18.46-1.481.262.09
Performance Ratios
   ROA(%)-6.31-12.23-3.242.775.93
   ROE(%)-12.83-20.53-6.106.6016.37
   ROCE(%)-5.94-25.66-3.579.7423.03
   Asset Turnover(x)1.610.642.062.332.90
   Sales/Fixed Asset(x)30.7616.3792.54134.63181.72
   Working Capital/Sales(x)4.151.474.475.938.10
Efficiency Ratios
   Fixed Capital/Sales(x)0.030.060.010.010.01
   Receivable days66.70255.91126.66115.6988.23
   Inventory Days78.11105.443.372.681.92
   Payable days100.12185.9568.3682.0767.31
Valuation Parameters
   PER(x)0.000.000.009.468.36
   PCE(x)-6.54-3.27-12.828.948.17
   Price/Book(x)0.790.720.750.601.29
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.200.580.180.100.16
   EV/Core EBITDA(x)-15.45-2.49-21.605.735.56
   EV/EBIT(x)-11.26-2.42-19.355.965.65
   EV/CE(x)0.310.380.450.260.47
   M Cap / Sales0.220.600.190.110.17
Growth Ratio
   Net Sales Growth(%)157.88-75.35-29.51-23.8816.84
   Core EBITDA Growth(%)85.36-593.31-131.83-52.46-6.96
   EBIT Growth(%)80.43-537.70-136.94-53.50-7.08
   PAT Growth(%)47.21-198.65-193.13-55.644.00
   EPS Growth(%)47.21-198.65-193.13-55.644.00
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.671.932.601.771.59
   Quick Ratio(x)1.181.202.631.741.60
   Interest Cover(x)-42.63-32.60-8.5516.6126.65
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.